(4-hydroxycyclohexyl) 4-methylbenzoate | 1036648-32-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (4-hydroxycyclohexyl) 4-methylbenzoate
• 英文别名: (4-Hydroxycyclohexyl) 4-methylbenzoate
• CAS: 1036648-32-4
• 化学式: C₁₄H₁₈O₃
• 分子量: 234.295
• InChiKey: JTHHFMZQBZQPFC-UHFFFAOYSA-N

物化性质

• 沸点：
  365.2±35.0 °C(Predicted)
• 密度：
  1.14±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (4-hydroxycyclohexyl) 4-methylbenzoate 在 甲醇 、 六甲基磷酰三胺 、 samarium diiodide 作用下， 以 四氢呋喃 为溶剂， 以98%的产率得到1,4-环己二醇
  参考文献：
  名称：

  Toluates: unexpectedly versatile reagents

  摘要：

  The mechanism of the monoelectronic reduction of aromatic esters has been investigated. The unexpected synthetic utility of the toluate moiety in the deoxygenation of alcohols and the allylation of ketones is also reported. Finally, the use of aromatic esters as robust, though easily removable, protecting groups is depicted. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2009.09.111
• 作为产物：
  描述：

  4-(4-methylbenzoyloxy)cyclohexyl 4-(trifluoromethyl)benzoate 在 tetrabutylammonium tetrafluoroborate 作用下， 以 N-甲基吡咯烷酮 、 异丙醇 为溶剂， 以80%的产率得到(4-hydroxycyclohexyl) 4-methylbenzoate
  参考文献：
  名称：

  Chemoselective Chemical and Electrochemical Deprotections of Aromatic Esters

  摘要：

  Alcohols can be easily and chemoselectively deprotected from the corresponding aromatic esters by using either Sml(2)/HMPA or by electrolysis in the presence of a proton source.

  DOI：

  10.1021/ol900828x

文献信息

• Organic electrosynthesis using toluates as simple and versatile radical precursors
  作者：Kevin Lam、István E. Markó

  DOI：10.1039/b813545b

  日期：——

  The electrolysis of toluateesters leads smoothly to the formation of the radical of the alkyl fragment. This property has been used to develop a new electrochemical deoxygenation reaction.

  甲酸酯类化合物的电解顺利地导致了烷基片段自由基的形成。这一特性已被用于开发一种新的电化学脱氧反应。
• [EN] PYRAZOLOPYRIMIDINE DERIVATIVES AS BTK INHIBITORS FOR THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE PYRAZOLOPYRIMIDINE COMME INHIBITEURS DE BTK POUR LE TRAITEMENT DU CANCER
  申请人：REDX PHARMA PLC

  公开号：WO2017046604A1

  公开（公告）日：2017-03-23

  This invention relates to novel compounds. The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK). The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia and immunological diseases.

  这项发明涉及新颖的化合物。该发明的化合物是酪氨酸激酶抑制剂。具体来说，该发明的化合物可用作布鲁顿氏酪氨酸激酶（BTK）的抑制剂。该发明还考虑了利用这些化合物治疗通过抑制布鲁顿氏酪氨酸激酶可治疗的疾病，例如癌症、淋巴瘤、白血病和免疫性疾病。
• SURFACE-MODIFIED INORGANIC NITRIDE, COMPOSITION, THERMALLY CONDUCTIVE MATERIAL, DEVICE PROVIDED WITH THERMALLY CONDUCTIVE LAYER
  申请人：FUJIFILM Corporation

  公开号：EP3653574A1

  公开（公告）日：2020-05-20

  An object of the present invention is to provide a surface-modified inorganic nitride having excellent dispersibility. Furthermore, another object of the present invention is to provide a composition, a thermally conductive material, and a device with a thermally conductive layer which contain the surface-modified inorganic nitride. The surface-modified inorganic nitride of the present invention includes an inorganic nitride, and a compound which is represented by General Formula (I) and is adsorbed onto a surface of the inorganic nitride.

  本发明的一个目的是提供一种具有优异分散性的表面改性无机氮化物。此外，本发明的另一个目的是提供一种含有表面改性无机氮化物的组合物、导热材料和带有导热层的设备。 本发明的表面改性无机氮化物包括无机氮化物，以及由通式（I）表示并吸附在无机氮化物表面的化合物。
• Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer
  申请人：Loxo Oncology, Inc.

  公开号：US10399990B2

  公开（公告）日：2019-09-03

  This invention relates to novel compounds. The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK). The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia and immunological diseases.

  本发明涉及新型化合物。本发明的化合物是酪氨酸激酶抑制剂。具体来说，本发明的化合物可用作布鲁顿酪氨酸激酶（BTK）的抑制剂。本发明还考虑将这些化合物用于治疗可通过抑制布鲁顿酪氨酸激酶治疗的疾病，例如癌症、淋巴瘤、白血病和免疫性疾病。
• Using Toluates as Simple and Versatile Radical Precursors
  作者：Kevin Lam、István E. Markó

  DOI：10.1021/ol800944p

  日期：2008.7.3

  The viability of the toluate moiety as a radical precursor has been examined by studying deoxygenation and cyclization reactions.